Growth hormone axis and visceral fat
Tesamorelin
A GHRH analog with real human data in a narrow lane.
Tesamorelin is one of the more legitimate growth-hormone-axis peptides because it has human data and an FDA-approved indication for HIV-associated lipodystrophy. Outside that lane, confidence drops.
Mechanism
What it probably does
Tesamorelin stimulates growth hormone release through GHRH receptor signaling, raising IGF-1 and influencing visceral adipose tissue metabolism.
Claims vs data
Where people get carried away
Human evidence exists, but mostly in a specific clinical population. Generalizing to every lean dude with belly fat is where the wheels get wobbly.
Why people use it
- •visceral fat
- •GH-axis support
- •body composition
- •IGF-1 response
What to track
- •IGF-1
- •fasting glucose
- •HbA1c
- •waist
- •sleep
- •blood pressure
- •edema
- •resting HR
In Short
Tesamorelin has real evidence. Just not for every claim people staple to it.
If IGF-1 rises and glucose worsens, you need to know that early.
Scientific evidence
Receipts before stories.
Anecdotal evidence
Not proof. Still useful signal.
Kabal angle
If you experiment, make the data impossible to ignore.
Kabal is built for the part most peptide pages skip: tracking the outcome, the dose, the timing, and the biomarkers that tell you whether the story holds up.
Get Kabal for iOS